Yoshiko Sakuma joined Mitsubishi Gas Chemical in 2008. She belonged to a biological research team including pharmaceutical antibody research team as engineer of quality control, optimization and manufacturing of CMO until 2015, and belonged to safety test team until 2019. Her current responsibilities are to evaluate OXCAPT™ with using commercially available drugs at Laboratory in Kanagawa prefecture in Japan.